Skip to main content
. 2019 Apr 1;8(4):24. doi: 10.1038/s41389-019-0133-3

Fig. 6. NK cells limit p53-mediated lung adenocarcinoma regression.

Fig. 6

Cohorts of mice were depleted for NK cells with α-NK1.1 antibody, or treated with an isotype control IgG and then orthotopically transplanted with KPr adenocarcinoma cells. Mice were treated with corn oil or tamoxifen and tumor burden was observed by bioluminescent imaging. a Representative bioluminescent images of C57BL6/J:Rag1-/- mice transplanted with KPrLG cells. Rag1-/- mice were inoculated with IgG or α-NK1.1 NK cell-depleting antibody on days −2, 2, and 5 (a, b). The initial treatment with corn oil (Control) or tamoxifen (Restored) is defined as day 0. Subsequent treatments indicated by arrows on X-axis. Images acquired relative to day 0 are from the same animal at the indicated time points. b Quantification of tumor burden from a. c Representative bioluminescent images of C57BL6/J:Rag1-/-;Il2rg-/- mice transplanted with KPrLG cells. Quantification of tumor burden is overlaid for comparison in b. Analysis of significance between control and restored groups was performed by two-way ANOVA. d Quantification of tumor burden from C57BL/6: Rag1-/-; Prf-/- transplanted with KPrLG cells and treated with corn oil (Control) or tamoxifen (Restored) at time points indicated by arrows. Values are normalized to day 0 measurements. Analysis of significance between control and restored groups was performed by t-test